Skip to main content

Advertisement

Log in

An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

To determine the risk factors of foot ulcers in diabetic patients indirectly via the measurement of advanced glycation end-products (AGE) with autofluorescence (AF). Between 2008 and 2009, a total of 195 diabetic inpatients, were recruited. Patients were categorized into those without foot ulcer, or with foot ulcer. Patients were followed up for 1 year via telephone and hospital visit. According to the first screening, mean values of skin AF were:2.29 ± 0.47 for subjects without foot ulcers and 2.80 ± 0.69 for those with foot ulcers, a significant difference(P < 0.05). Follow-up was conducted via telephone in 149 patients, and there were no significant changes in disease condition of both groups. Additionally, 34 patients were further followed-up via hospital visit. Each variable of these patients after follow-up was closely related to the corresponding one before follow-up (P < 0.05). Glycosylated hemoglobin (HbA1c) levels markedly declined, and high-density lipoprotein (HDL) cholesterol levels and VPT were significantly increased, after follow-up (P < 0.05). Moreover, there were no significant changes in AF value and ABI during follow-up. AF, which is associated with in vivo AGE levels, is also closely related to various risk factors of foot ulcers in diabetic patients. Our follow-up duration was relatively short, and thus, more studies with longer follow-up periods are warranted to confirm the role of AF as a risk factor for foot ulcers in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(5 Suppl):S1–66.

    PubMed  Google Scholar 

  2. Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008;24 Suppl 1:S19–24.

    Article  PubMed  CAS  Google Scholar 

  3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.

    Article  PubMed  CAS  Google Scholar 

  4. Facchiano F, Lentini A, Fogliano V, Mancarella S, Rossi C, Facchiano A, et al. Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo. Am J Pathol. 2002;161:531–41.

    Article  PubMed  CAS  Google Scholar 

  5. Portero-Otin M, Pamplona R, Bellmunt MJ, Ruiz MC, Prat J, Salvayre R, et al. Advanced glycation end product precursors impair epidermal growth factor receptor signaling. Diabetes. 2002;51:1535–42.

    Article  PubMed  CAS  Google Scholar 

  6. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol. 2001;159:513–25.

    Article  PubMed  CAS  Google Scholar 

  7. Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 2003;52:2805–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

The authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chunmao Han.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, H., Jin, X., Jiang, H. et al. An observational study of foot ulceration risk in diabetic patients evaluated with autofluorescence: 195 cases cross-sectional and one-year outcome. Int J Diabetes Dev Ctries 33, 18–22 (2013). https://doi.org/10.1007/s13410-012-0098-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-012-0098-7

Keywords

Navigation